Pharmaceutical giant Pfizer, and life sciences tools provider Thermo Fisher Scientific announced today they will collaborate to help expand local access to NGS-based lung cancer and breast cancer testing in more than 30 countries in Latin America, Africa, and the Middle East in areas where these tests and technologies have…

Genetic testing could determine which young breast cancer survivors are at highest risk of a second primary breast cancer (SPBC) and thus help others avoid unnecessary treatment, according to a new study. Their findings suggests young breast cancer survivors without a germline pathogenic variant have a low risk of developing…

Preliminary data from a survey of patients with breast cancer conducted in five European countries by Cancer Patients Europe’s (CPE) Cancer my Concern (myC) initiative found that four-in-five patients eligible for genomic testing are not told it is available to them. Further, despite the proven utility of such testing for…

A new study from researchers at the Mayo Clinic Cancer Center and collaborators from the CARRIERS consortium suggests that women over 65 with breast cancer could benefit from hereditary cancer genetic testing. These results, the researchers say, could affect further diagnostic testing, prevention, and treatment. The study was published in…

Testing positive for a high-risk breast cancer gene doesn’t always lead to the most appropriate care, a new study finds. Women who tested positive for such variants were more likely to receive bilateral mastectomy, which is in line with current guidelines.  But they were also less likely to receive radiotherapy…

Today Color Genomics unveiled the Benefits Program for Genetic Testing for Breast and Ovarian Cancer Risk, a first-of-its-kind initiative to offer this type of testing to an organization’s employee base. The initial partners include 18 organizations from the Bay Area and surrounding area, who are pledging to offer their employees…

A new study, published this week in the Annals of Internal Medicine, finds total expenditures for cancer screening in the U.S. topped $43 billion based on 2021 data. The research, led by Michael Halpern, MD, PhD, from the National Institutes of Health (NIH), used national health survey and resources data…

Earlier this year, Princess Kate Middleton announced that she had cancer. The world responded with shock, partly because she’s only 42. Her 75-year-old father-in-law, King Charles, was also diagnosed almost simultaneously. His announcement drew widespread sympathy as well, but nothing like the shock that greeted Kate’s news. “She is so…

A new study from the Mayo Clinic finds that current screening protocols fail to catch a significant number of individuals with genetic mutations linked to hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome, which increase the risk of developing certain cancers. Their findings, published in JCO Precision Oncology,…

Many breast cancer survivors eligible for genetic counseling and testing are not receiving it according to a new study from the University of Michigan (U-M) Health Rogel Cancer Center. This is increasingly important as cancer treatment and follow up are getting more complex as more new drugs are being introduced.…

Researchers have known for some time that about seven percent of people diagnosed with low-risk prostate cancer following a biopsy actually have the deadly form of the disease. Recently, some experts have called for the lowest grade of prostate cancer—biopsy Gleason Grade Group (GGG) 1—to be reclassified as “benign.” A…

Real-time AI assistance led to much greater efficiency and lower cost, in a study by Dutch researchers of sentinel node biopsies for breast cancer. Sentinel lymph nodes (SNs) are the first lymph nodes to drain lymphatic flow from the tumor. Testing them can be a difficult and time-consuming process.  This…

As a graduate student at the Hebrew University’s Interdisciplinary Center for Neuronal Computation in the late 1990s, Tuvik Beker, PhD, applied his mathematics and machine learning training to investigate the use of artificial neural networks to solve complex problems. Twenty years later, after a long and winding road of applying…

Scientists from Cambridge University and University College London report they have trained an artificial intelligence (AI) model to examine DNA methylation patterns that has identified 13 different types of cancer with 98.2% accuracy. Their work, published in Biology Methods & Protocols, demonstrate that is may soon be possible to deploy…

Just as 23andMe, once direct-to-consumer (DTC) testing’s darling, faced a huge drop in share value and once hot startup LunaDNA was shuttering, Panacea was promoting its new DTC genetic testing service. This might seem counter-intuitive, but consumer genetics is far from dead, even the DTC version. Panacea, for example, says…